Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer.

"Declarations Ethics approval and consent to participateThe informed consent was obtained from all subjects. The experiments on the use of human tissue samples were carried out in accordance with relevant guidelines and regulations. The Ethics Committee of Department of Respiratory and Sleep Medicine, the First Affiliated Hospital of Zhengzhou University approved human participants involving in this study. The ethical approval number was 2021-KY-1057-002. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the Natural Science Foundation of Henan Province (Grant Number 232300421172), and the Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences (Grant Number 2023BP0204). We gratefully acknowledge Henan Key Laboratory of Pharmacology for Liver Diseases for providing platform support."